Supavadee Amatayakul‐Chantler
CSL (Australia)(AU)CSL (Switzerland)(CH)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Glycosylation and Glycoproteins Research, SARS-CoV-2 detection and testing, Long-Term Effects of COVID-19
Most-Cited Works
- → Heart and Liver Defects and Reduced Transforming Growth Factor β2 Sensitivity in Transforming Growth Factor β Type III Receptor-Deficient Embryos(2003)248 cited
- → Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure.(1994)211 cited
- → SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern(2022)156 cited
- → Structural analysis of the N-glycans from human immunoglobulin A1: comparison of normal human serum immunoglobulin A1 with that isolated from patients with rheumatoid arthritis(1994)97 cited
- → SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern(2021)72 cited
- → Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level(2023)54 cited
- → Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia(2022)54 cited
- → Characterization of distinct functional domains of transforming growth factor beta.(1993)36 cited
- → [Ser77]transforming growth factor-beta 1. Selective biological activity and receptor binding in mink lung epithelial cells.(1994)31 cited
- → Cell surface oligosaccharides on Dictyostelium during development(1991)16 cited